Package 67296-2146-1

{"route": ["ORAL"], "spl_id": "4ca9cf49-74e1-1ef8-e063-6294a90aeae4", "openfda": {"unii": ["G447S0T1VC"], "spl_set_id": ["3251a0f1-cbfd-c9d6-e063-6394a90a09a0"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE (67296-2146-1)", "package_ndc": "67296-2146-1", "marketing_start_date": "20230214"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (67296-2146-3)", "package_ndc": "67296-2146-3", "marketing_start_date": "20230214"}], "brand_name": "Valacyclovir", "product_id": "67296-2146_4ca9cf49-74e1-1ef8-e063-6294a90aeae4", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "67296-2146", "generic_name": "Valacyclovir", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20271231"}